AIM: The aim of this study was to develop quality indicators for physiotherapy in Parkinson's disease (PD) according to international criteria. METHODS: Indicators were based on an evidence-based guideline for physiotherapy in PD. Guideline recommendations were transformed into indicators and rated for their relevance by an expert panel. Relevant indicators were incorporated into a questionnaire termed ''Quality Indicators for Physiotherapy in PD'' (QIP-PD). The QIP-PD was piloted among 105 physiotherapists. The adjusted version was evaluated in 46 physiotherapists with specific expertise in PD and in 795 general physiotherapists. The following clinimetric aspects of the QIP-PD were tested: completeness of answers, response distribution, internal consistency, and discriminative power. The reliability of the QIP-PD was evaluated by interviews among a randomly selected cohort of 32 PD experts and 32 general physiotherapists. RESULTS: The expert panel selected 16 indicators, which were transformed into an adjusted 17-item QIP-PD. The adjusted QIP-PD was completed by 41 expert physiotherapists and 286 general physiotherapists. Comple-teness of item scores ranged from 95-98%. Six items were excluded from the final analyses as they showed ceiling effect among both groups, or lacked discriminative power. The total QIP-PD score for the 11 items was significantly higher for expert physiotherapists (35.1+/-4.2) compared to general physiotherapists (22.2+/-7.7; P=0.01). Internal consistency was good (Crohnbach's alpha 0.84). QIP-PD scores of therapists and interviewers (correlated using Intraclass Correlations Coefficients) ranged from 0.63 to 0.75. CONCLUSIONS: The QIP-PD is a relevant, feasible, valid, discriminative and reliable instrument to measure adherence to guidelines for physiotherapy in PD. In addition, the results underscore that quality improvement interventions for physiotherapy in PD are needed, as guideline adherence is suboptimal in physiotherapists without specific PD expertise.
AIM: The aim of this study was to develop quality indicators for physiotherapy in Parkinson's disease (PD) according to international criteria. METHODS: Indicators were based on an evidence-based guideline for physiotherapy in PD. Guideline recommendations were transformed into indicators and rated for their relevance by an expert panel. Relevant indicators were incorporated into a questionnaire termed ''Quality Indicators for Physiotherapy in PD'' (QIP-PD). The QIP-PD was piloted among 105 physiotherapists. The adjusted version was evaluated in 46 physiotherapists with specific expertise in PD and in 795 general physiotherapists. The following clinimetric aspects of the QIP-PD were tested: completeness of answers, response distribution, internal consistency, and discriminative power. The reliability of the QIP-PD was evaluated by interviews among a randomly selected cohort of 32 PD experts and 32 general physiotherapists. RESULTS: The expert panel selected 16 indicators, which were transformed into an adjusted 17-item QIP-PD. The adjusted QIP-PD was completed by 41 expert physiotherapists and 286 general physiotherapists. Comple-teness of item scores ranged from 95-98%. Six items were excluded from the final analyses as they showed ceiling effect among both groups, or lacked discriminative power. The total QIP-PD score for the 11 items was significantly higher for expert physiotherapists (35.1+/-4.2) compared to general physiotherapists (22.2+/-7.7; P=0.01). Internal consistency was good (Crohnbach's alpha 0.84). QIP-PD scores of therapists and interviewers (correlated using Intraclass Correlations Coefficients) ranged from 0.63 to 0.75. CONCLUSIONS: The QIP-PD is a relevant, feasible, valid, discriminative and reliable instrument to measure adherence to guidelines for physiotherapy in PD. In addition, the results underscore that quality improvement interventions for physiotherapy in PD are needed, as guideline adherence is suboptimal in physiotherapists without specific PD expertise.
Authors: Paul de Roos; Bastiaan R Bloem; Thomas A Kelley; Angelo Antonini; Richard Dodel; Peter Hagell; Connie Marras; Pablo Martinez-Martin; Shyamal H Mehta; Per Odin; Kallol Ray Chaudhuri; Daniel Weintraub; Bil Wilson; Ryan J Uitti Journal: J Parkinsons Dis Date: 2017 Impact factor: 5.568
Authors: Rob Ab Oostendorp; Hans Elvers; Emiel van Trijffel; Geert M Rutten; Gwendolyne Gm Scholten-Peeters; Marcel Heijmans; Erik Hendriks; Emilia Mikolajewska; Margot De Kooning; Marjan Laekeman; Jo Nijs; Nathalie Roussel; Han Samwel Journal: Patient Prefer Adherence Date: 2018-11-08 Impact factor: 2.711
Authors: Rob A B Oostendorp; Hans Elvers; Emiel van Trijffel; Geert M Rutten; Gwendolyne G M Scholten-Peeters; Margot De Kooning; Marjan Laekeman; Jo Nijs; Nathalie Roussel; Han Samwel Journal: Front Pain Res (Lausanne) Date: 2022-08-30
Authors: Rob A B Oostendorp; J W Hans Elvers; Emiel van Trijffel; Geert M Rutten; Gwendolyne G M Scholten-Peeters; Marcel Heijmans; Erik Hendriks; Emilia Mikolajewska; Margot De Kooning; Marjan Laekeman; Jo Nijs; Nathalie Roussel; Han Samwel Journal: Patient Prefer Adherence Date: 2020-03-02 Impact factor: 2.711
Authors: Anouk Tosserams; Maarten J Nijkrake; Ingrid H W M Sturkenboom; Bastiaan R Bloem; Jorik Nonnekes Journal: J Parkinsons Dis Date: 2020 Impact factor: 5.568